SA
ARKG icon

Strategic Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Strategic Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,235
Closed -$217K – 203
2024
Q2 		$217K Sell
9,235
-1,798
-16% -$45.4K 0.04% 191
2024
Q1 		$317K Hold
11,033
– – 0.06% 169
2023
Q4 		$362K Sell
11,033
-319
-3% -$8.67K 0.07% 157
2023
Q3 		$316K Sell
11,352
-47
-0.4% -$1.54K 0.06% 160
2023
Q2 		$389K Sell
11,399
-87
-0.8% -$2.73K 0.07% 145
2023
Q1 		$345K Sell
11,486
-6,656
-37% -$206K 0.07% 154
2022
Q4 		$512K Sell
18,142
-127
-0.7% -$4.03K 0.11% 125
2022
Q3 		$600K Sell
18,269
-471
-3% -$17.3K 0.13% 120
2022
Q2 		$590K Sell
18,740
-1,373
-7% -$48K 0.12% 121
2022
Q1 		$923K Sell
20,113
-1,758
-8% -$83.8K 0.16% 107
2021
Q4 		$1.34M Sell
21,871
-16,193
-43% -$1.12M 0.19% 97
2021
Q3 		$2.84M Buy
38,064
+858
+2% +$72K 0.61% 32
2021
Q2 		$3.44M Sell
37,206
-20,794
-36% -$1.77M 0.89% 23
2021
Q1 		$5.15M Buy
58,000
+647
+1% +$64.2K 1.49% 17
2020
Q4 		$5.93M Buy
57,353
+24,936
+77% +$1.99M 1.71% 15
2020
Q3 		$2.18M Buy
32,417
+6,540
+25% +$383K 0.73% 32
2020
Q2 		$1.48M Buy
25,877
+14,057
+119% +$603K 0.55% 38
2020
Q1 		$385K Buy
11,820
+3,707
+46% +$124K 0.17% 101
2019
Q4 		$272K Buy
8,113
+807
+11% +$25.6K 0.09% 144
2019
Q3 		$216K Buy
+7,306
New +$237K 0.08% 158

Other funds holding ARKG

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Strategic Advisors's ARKG Position: Q3 2024 in Review

Strategic Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 9,235 shares — an estimated $217K sold.

Strategic Advisors first reported a position in ARKG in Q3 2019 and held it in 20 quarters. The position peaked at $5.93M in Q4 2020. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Strategic Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • Strategic Advisors sold 9,235 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $217K.
  • Strategic Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2019 and held it in 20 quarters.
  • Strategic Advisors's ARK Genomic Revolution ETF position peaked at $5.93M in Q4 2020.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Strategic Advisors's 13F filing for Q3 2024, filed 9 Oct 2024.